Search

Your search keyword '"Johnson, Christina"' showing total 235 results

Search Constraints

Start Over You searched for: Author "Johnson, Christina" Remove constraint Author: "Johnson, Christina" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
235 results on '"Johnson, Christina"'

Search Results

3. Meta-analysis of the space flight and microgravity response of the Arabidopsis plant transcriptome

4. Obstetric comorbidity scores and disparities in severe maternal morbidity across marginalized groups.

6. Comparison between the old and new MFMU TOLAC Calculator – Which is more accurate?

7. Say My Name: Understanding the Power of Names, Correct Pronunciation, and Personal Narratives

9. A Randomized Trial of Quadruple-Fortified Salt for Anemia and Birth Defects Prevention in Southern India: Protocol Design and Methods

10. Equitable implementation of S.A.F.E. Firearm: A multi-method pilot study

16. Evaluation of IMproving Palliative care Education and Training Using Simulation in Dementia (IMPETUS-D) a staff simulation training intervention to improve palliative care of people with advanced dementia living in nursing homes: a cluster randomised controlled trial

17. Addressing Cardiovascular Risk in People With Psoriatic Disease Using a Care Coordinator Model: A Qualitative Analysis of a Pilot Study.

18. Family cascade screening for equitable identification of familial hypercholesterolemia: study protocol for a hybrid effectiveness-implementation type III randomized controlled trial

19. Implementation of a Secure Firearm Storage Program in Pediatric Primary Care: A Cluster Randomized Trial

21. Study protocol for a type III hybrid effectiveness-implementation trial of strategies to implement firearm safety promotion as a universal suicide prevention strategy in pediatric primary care

24. P17-025-23 A Randomized Crossover Trial To Evaluate the Acceptability of Quadruple-Fortified Salt in Women and Their Households in Southern India

25. P11-025-23 Arsenic Exposure, One-Carbon Metabolism Biomarkers, and Population-Based Risk of Neural Tube Defects

26. The consequences of tetraploidy onCaenorhabditis elegansphysiology and sensitivity to chemotherapeutics

27. Win the Performance Improvement Race: Learning at Speed: How to Upskill and Reskill Your Workforce at Pace to Drive Business Performance

28. Outcomes of the "BRCA Quality Improvement Dissemination Program": An initiative to improve patient receipt of cancer genetics services at five health systems

29. Estimating the serum folate concentration that corresponds to the red blood cell folate concentration threshold associated with optimal neural tube defects prevention: A population-based biomarker survey in Southern India

30. Data from Targeting Sphingosine Kinase Induces Apoptosis and Tumor Regression for KSHV-Associated Primary Effusion Lymphoma

31. Supplementary Figure Legend from Targeting Sphingosine Kinase Induces Apoptosis and Tumor Regression for KSHV-Associated Primary Effusion Lymphoma

32. Supplementary Table 1 from Targeting Sphingosine Kinase Induces Apoptosis and Tumor Regression for KSHV-Associated Primary Effusion Lymphoma

33. Supplementary Figure 3 from Targeting Sphingosine Kinase Induces Apoptosis and Tumor Regression for KSHV-Associated Primary Effusion Lymphoma

34. Supplementary Figure 1 from Targeting Sphingosine Kinase Induces Apoptosis and Tumor Regression for KSHV-Associated Primary Effusion Lymphoma

35. Supplementary Figure 2 from Targeting Sphingosine Kinase Induces Apoptosis and Tumor Regression for KSHV-Associated Primary Effusion Lymphoma

38. Supplementary Data from 17-Allylamino-17-Demethoxygeldanamycin and MEK1/2 Inhibitors Kill GI Tumor Cells via Ca2+-Dependent Suppression of GRP78/BiP and Induction of Ceramide and Reactive Oxygen Species

40. Data from MDA-7/IL-24–induced cell killing in malignant renal carcinoma cells occurs by a ceramide/CD95/PERK–dependent mechanism

42. Data from 17-Allylamino-17-Demethoxygeldanamycin and MEK1/2 Inhibitors Kill GI Tumor Cells via Ca2+-Dependent Suppression of GRP78/BiP and Induction of Ceramide and Reactive Oxygen Species

45. Supplementary Fig. from MDA-7/IL-24–induced cell killing in malignant renal carcinoma cells occurs by a ceramide/CD95/PERK–dependent mechanism

46. Supplementary Figure 4 from Promoting Thiol Expression Increases the Durability of Antitumor T-cell Functions

47. Supplementary Figure 2 from Promoting Thiol Expression Increases the Durability of Antitumor T-cell Functions

48. Data from Vorinostat and Sorafenib Increase CD95 Activation in Gastrointestinal Tumor Cells through a Ca2+-De novo Ceramide-PP2A-Reactive Oxygen Species–Dependent Signaling Pathway

49. Supplementary Material and Methods from Promoting Thiol Expression Increases the Durability of Antitumor T-cell Functions

50. Data from Promoting Thiol Expression Increases the Durability of Antitumor T-cell Functions

Catalog

Books, media, physical & digital resources